polski | english | login
Array|Array|Array|Array|Array|Array

DOI: 10.18544/PEDM-22.01.0048
Pediatr Endocrinol Diabetes Metab 2016;24,1:32-38

Vitamin D and metabolic, autoimmunologic and neoplasm diseases

Karolina Galant, Ewa Barg, Bernarda Kazanowska

Key words:

vitamin D, metabolic diseases, neoplasia diseases, vitamin D receptor

Abstract

At the turn of the 19th and 20th century McColum made the discovery of vitamin D as a result of the research on cod liver oil, in order to identify substances having anti ricets effect. Since that time, knowledge of its role in the human body systematically increases. For many years it was thought that it only plays a role in regulating calcium economy. The discovery in the mid-1970s of the presence of VDR- Vitamin D Receptor in most cells of the human body have turned attention to its pleiotropic effect. Special attention deserves wit. D impact on the risk of metabolic diseases and of pre-neoplasia as well as the long-term effects of the treatment of these diseases. The article presents a short review of the results of previously conducted studies on these issues.


Article published in polish language



advanced search »

Article in databases

DOI: 10.18544/PEDM-22.01.0048
PUBMED: view

Similar articles

...

The Pro12Ala PPARg2 gene polymorphism involves residual C-peptide secret ...

Insulin-like growth factor-1 (IGF-1) – structure and the role in the hum ...

Cardiometabolic risk factors in Turner syndrome ...

Response to low dose indomethacin in two children with nephrogenic diabe ...

Pediatric Endocrinology Diabetes and Metabolism

2018; 24, 1: 1-51
2017; 23, 4: 169-222
2017; 23, 3: 117-168
2017; 23, 2: 59-116
2017; 23, 1: 1-58
2016; 22, 4: 133-180
2016; 22, 3: 81-132
2016; 22, 2: 43-79
2016; 22, 1: 1-42
2015; 21, 4: 149-191
2015; 21, 3: 97-148
2015; 21, 2: 51-96
2015; 21, 1: 1-50
2014; 20, 4: 131-182
2014; 20, 3: 83-130
2014; 20, 2: 35-82